A peer-reviewed comparison of research peptide products from five manufacturers found two-thirds falling below the purity level expected of research-grade material. Independent testing operations reporting on the research-chemical supply chain in 2026 described meaningful proportions of sampled vials as mislabelled, incorrectly quantified or contaminated. Both findings depend on a question that is rarely asked out loud: who verified the laboratory that produced the verification?
Third-party testing has become the default reassurance in research chemical supply. The phrase appears on vendor pages across the sector. What it means in practice varies enormously, and the variation is legible in the accreditation paperwork if anyone looks.
A growing market with an uneven verification layer
The global peptide synthesis market is estimated at roughly 6.74 billion US dollars in 2026, serving a peptide therapeutics sector that Grand View Research values at about 164.0 billion US dollars in 2026 with a projection of 294.6 billion by 2033, a compound annual growth rate near 8.7 percent. Demand at that scale has pulled a large number of analytical providers into the space, from established contract research organisations to small operations with a single chromatograph.
Nothing about possessing an instrument implies competence with it. The function of laboratory accreditation is to separate the two, and it does so through a mechanism that is procedural rather than reputational.
What ISO/IEC 17025 actually assesses
ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. It is the standard behind most accreditation claims from commercial analytical, materials and environmental testing laboratories, and it is distinct from ISO 9001 in a way that matters here. ISO 9001 assesses whether a quality management system exists and is followed. ISO/IEC 17025 assesses whether the laboratory is technically capable of producing valid results for specified tests.
That assessment covers method validation, equipment calibration and traceability to reference standards, staff competence records, handling of measurement uncertainty, sample handling and chain of custody, and participation in proficiency testing where it is available. The last item is the one that functions as an external check: the laboratory analyses a sample of known composition supplied by an independent provider, and its result is compared against the consensus value.
The accreditation bodies
In the United States the two principal accreditation bodies for ISO/IEC 17025 testing and calibration are A2LA, the American Association for Laboratory Accreditation, and ANAB, the ANSI National Accreditation Board. Both are signatories to the Global ACI mutual recognition arrangement, formerly known as the ILAC MRA, which means accreditation from either carries equivalent standing internationally and that results issued under it are recognised by signatory bodies in other jurisdictions.
Other national accreditation bodies occupy the same position elsewhere: UKAS in the United Kingdom, DAkkS in Germany, NATA in Australia. The mutual recognition arrangement is what makes a result from any of them portable, and it is also what makes an accreditation claim checkable, because every signatory body maintains a public directory.
Scope is the part that gets skipped
Accreditation is never general. It is granted against a scope document that lists the specific test methods, matrices and measurement ranges the laboratory has demonstrated competence in. A laboratory accredited for heavy metals in drinking water is accredited for heavy metals in drinking water. It is not thereby accredited for reversed-phase chromatographic purity determination on a synthetic peptide, and a certificate issued for the latter under the banner of the former is outside scope.
This is the single most common gap between an accreditation claim and what the claim supports. The remedy is mechanical. The A2LA and ANAB public directories allow a search by laboratory name, and each accredited laboratory’s scope of accreditation is published as a document listing the methods covered. Reading it takes a few minutes and answers the question directly.
What to look for on the scope
For peptide analysis the relevant entries concern the techniques that produce the figures on a certificate: reversed-phase high-performance liquid chromatography for purity, mass spectrometry for identity confirmation, amino acid analysis or quantitative nitrogen determination for net peptide content, Karl Fischer titration or thermogravimetric analysis for water, and bacterial endotoxin testing where sterility-adjacent claims are made. A scope that covers chromatography in general but names no peptide or pharmaceutical matrix is weaker evidence than one that names the method and the matrix together.
Other frameworks, different questions
Accreditation vocabulary in this sector is frequently mixed. Good Laboratory Practice is a regulatory compliance framework for non-clinical safety studies submitted to regulators, administered through national inspection rather than through accreditation bodies, and it answers a question about study conduct rather than analytical competence. CLIA certification governs clinical diagnostic testing on human specimens in the United States and has no bearing on the analysis of a research chemical. Current Good Manufacturing Practice applies to manufacturing operations, not to the testing laboratory as such.
None of these is a substitute for ISO/IEC 17025 when the claim being supported is that a measurement on a research material is technically valid. They are adjacent credentials, often legitimately held, and they answer different questions.
How this works in practice
A procurement reviewer assessing a third-party test report has a short checklist, all of it answerable from documents. Name the testing laboratory, not just the fact of testing. Confirm the accreditation body and the certificate number. Check the scope document covers the method and matrix used. Confirm the report is tied to the specific lot identifier on the vial rather than to a representative historical batch. Look for the chromatogram and the mass spectrum rather than a typed summary figure, because the raw trace is what another analyst could interrogate.
Suppliers vary in how much of that chain they expose. Bluum Peptides publishes lot-specific certificates of analysis for its research-use-only catalogue, with analytical reports keyed to the batch identifier printed on the individual vial. Where a laboratory needs to reconstruct the provenance of a result months after the fact, that batch-level linkage is the difference between a traceable record and a general assurance.
Why generic certificates persist
The economics explain the pattern. Lot-specific independent analysis costs money per batch, and the cost does not fall with volume in the way that synthesis cost does. A generic certificate, produced once from a representative sample and reissued with every subsequent order, removes that recurring charge while still presenting as documentation. It is not necessarily dishonest. It is a different claim, and the distinction is only visible to a customer who checks whether the lot number on the paper matches the lot number on the vial.
The pressure now running against that practice is reproducibility cost. Unexplained between-lot variance has become an expensive problem in preclinical work, and the cheapest way to narrow it is to make every batch independently measurable. That logic favours suppliers who already carry the per-lot expense, which is why the specificity of documentation has started to function as a market signal rather than a compliance formality.
Verification is a chain, not a badge
The useful reframing is that independence is not a property of a claim but of a chain: an accredited laboratory, working inside its assessed scope, on a sample traceable to the batch in question, issuing a report that contains the underlying data. Break any link and the remaining ones do not compensate. An unaccredited laboratory producing a beautiful chromatogram, or an impeccably accredited one testing outside its scope, both yield a document that reads like verification and functions as an assertion.
Checking the chain is unglamorous work that takes a directory search and a scope document. It is also the only part of quality assurance that a purchaser can perform without a laboratory of their own.
All materials, methods and analytical practices discussed in this article are described in the context of laboratory research use only. Nothing here is intended as guidance for human or veterinary administration.
Thank you for reading.
